The 2026 WHO dementia guidelines do not support taking vitamin B, vitamin E, omega-3 or multivitamins solely to prevent cognitive decline or dementia. They support treating a diagnosed deficiency and focusing on proven risk factors instead.
Dementia means progressive loss of memory and thinking skills that interferes with daily life. WHO released the second edition of its Risk reduction of cognitive decline and dementia guidelines on 15 July 2026, updating the first 2019 edition, according to the WHO announcement. The non-recommendation covers routine supplement use by people without deficiency.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Read the official guidance from Who — Use this primary source to verify the official guidance.
- Read the official guidance from Un — Use this primary source to verify the official guidance.
Table of Contents
- Which products does the guidance cover?
- Why did WHO decide against routine use?
- What if you have a deficiency?
- What helps prevent or delay dementia?
Which products does the guidance cover?
The guidance names four product groups: vitamin B supplements, vitamin E supplements, omega-3 PUFA supplements, and multivitamin or mineral supplements. It addresses their use solely to prevent cognitive decline or dementia. It does not address foods, fortified diets, or prescriptions for other health reasons.
The key word is routine. WHO does not recommend that adults without deficiency take these products as a brain-health habit. A person who buys them only for dementia prevention gains no supported benefit.
Why did WHO decide against routine use?
WHO concluded current evidence does not show potential benefits outweigh possible unexpected harmful effects in people without deficiency, as reported by UN News on the WHO findings. The problem is lack of benefit-harm evidence rather than proven harm from every supplement. In practical terms, the balance does not favor routine use.
This distinction matters for readers. Insufficient evidence is not proof of zero effect for all people and doses. It means trials have not shown a clear net gain worth recommending to whole populations.
What if you have a deficiency?
The non-recommendation applies only absent diagnosed deficiency. It does not advise against treating a clinically diagnosed vitamin or mineral deficiency. Low B12, low vitamin D, iron deficiency, and similar conditions still need medical care.
Ask a clinician about testing when deficiency signs are present. Examples include lasting fatigue, numbness, pale skin, mouth sores, or a very restricted diet. Do not stop or start a prescribed supplement because of the dementia guidance alone.
What helps prevent or delay dementia?
WHO estimates up to 45 percent of dementia risk could be prevented or delayed by addressing modifiable factors, according to the WHO announcement. That share is large because dementia affects over 57 million people, with nearly 10 million new cases yearly, according to UN News on the WHO findings.
Health systems should build these steps into noncommunicable-disease and brain-health care. For readers, the practical move is to skip B, E, omega-3, or multivitamins bought only for dementia prevention and put that effort into blood-pressure control, exercise, sleep, and not smoking.
- Avoid tobacco and limit alcohol.
- Stay physically, mentally, and socially active.
- Manage blood pressure, diabetes, cholesterol, weight, and depression.
- Reduce exposure to air pollution and prevent head injury.
